Skip to content

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

Renal Effects of Carbetocin and Oxytocin in Cesarean Section for Preventing Post-partum Haemorrhage: a Prospective Randomized Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03939806
Enrollment
100
Registered
2019-05-07
Start date
2019-05-31
Completion date
2019-06-30
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage

Brief summary

The aim of this study is to evaluate the renal outcome of patients undergoing elective C/S where oxytocin or carbetocin is used for postpartum hemorrhage prophylaxis.

Interventions

DRUGOxytocin

To be given to Oxytocin group following the clamping of the umbilical cord

DRUGCarbetocin

To be given to Carbetocin group following the clamping of the umbilical cord

Sponsors

Ufuk University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Term (\>37 weeks of gestation) uncomplicated pregnant women undergoing elective cesarean section

Exclusion criteria

* Patients refusing to participate in the study * Complicated pregnancies * Patients with risk factors for postpartum hemorrhage * Contraindications for oxytocin or carbetocin usage * Patients with known renal diseases * Preterm births (\<37 weeks of gestation)

Design outcomes

Primary

MeasureTime frameDescription
Urine volumeIntraoperative periodTotal amount of intraoperative urine output in milliliters
Urinary sodiumPreoperative, Postoperative 2nd, 4th, 24th hoursThe change in urinary sodium content (milligrams) compared to the preoperative period
Blood sodiumPreoperative, Postoperative 2nd, 4th, 24th hoursThe change in blood sodium content (milligrams) compared to the preoperative period

Secondary

MeasureTime frameDescription
Blood transfusionStarting from the clamping of the umbilical cord, ending at the 24th postoperative hourTotal volume (milliliters) of blood transfused
Need for additional uterotonicsStarting from the preoperative period, ending at the 24th postoperative hourTotal dose (milligrams) of additional uterotonics administered
Blood osmolalityPreoperative, Postoperative 2nd, 4th, 24th hoursThe change in blood osmolality compared to the preoperative period
Blood lossIntraoperative periodThe total volume of intraoperative blood loss

Countries

Turkey (Türkiye)

Contacts

Primary ContactGamze S Çağlar, Prof.Dr.
gamzesinem@hotmail.com+903122044000
Backup ContactBaturay K Kazbek, MD
bkkazbek@gmail.com+903122044000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026